Fosun Pharma definition

Fosun Pharma means Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司), a company incorporated under the laws of the PRC, having its registered address at 0/X, 000 Xxxxxxx Xxxx, Xxxxxxxx and 100% owner of Fosun Industrial.
Fosun Pharma shall have the meaning set forth in the Preamble.
Fosun Pharma means Shanghai Fosun Pharmaceutical (Group) Co., Ltd., a company incorporated in the PRC.

Examples of Fosun Pharma in a sentence

  • BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer.

  • Teachers teaching on call shall be paid an additional compensation of $3 ($11 effective January 1, 2016,) over daily rate in lieu of benefits.

  • Mr. Lior Moshe Dayan is the Chief Executive Officer of the Company, which is a subsidiary of Fosun Pharma.

  • Fosun Pharma is a leading healthcare company in the PRC and primarily engaged in business segments including pharmaceutical manufacturing, pharmaceutical distribution and retail, healthcare services and medical diagnosis and medical devices.

  • BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer.

  • Fosun Pharma, has marketing and distribution rights in China, Hong Kong special administrative region, or SAR, Macau SAR and the region of Taiwan.

  • Therefore, Fosun Pharma Industrial Development is a connected person of the Company by virtue of being an associate of the Company’s controlling shareholder.

  • Fosun High Tech was deemed to be interested in the Domestic Shares and H Shares which Fosun Pharma was interested in.

  • As part of our growth strategy, we aim to, among other things, expand our product portfolio and delivery systems to drive revenue growth; continue to invest in manufacturing and related technological capabilities to meet future demand; increase current market presence and enter new markets; align with Shanghai Fosun Pharma to increase market share; pursue strategic acquisitions and partnerships; and continue to focus on cost management.

  • BNT162b2 is one of several lipid nanoparticle-formulated, nucleoside-modified messenger RNA vaccines against SARS-CoV-2 developed within “Project Lightspeed” launched by BioNTech, in collaboration with Pfizer and Fosun Pharma.


More Definitions of Fosun Pharma

Fosun Pharma means Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司), a company incorporated under the laws of the PRC, having its registered address at 9/F, 510 Caoyang Road, Shanghai and 100% owner of Fosun Industrial.

Related to Fosun Pharma

  • CMBI means Chase Manhattan Bank International, an indirect wholly-owned subsidiary of Bank, located in Moscow, Russia, and any nominee companies appointed by it.

  • Elan means Elan Corp and its Affiliates.

  • BG means Bank Guarantee

  • NPS means nominal pipe size.

  • We/Our/Us means the Underwriters named in the Schedule.

  • Raptor means all birds of the orders Falconiformes and Strigiformes, commonly called falcons,

  • Novartis shall have the meaning set forth in the Preamble.

  • CIMA means the Cayman Islands Monetary Authority whose contact details are available from www.cima.ky;

  • EPIC means the estates and protected individuals code, 1998 PA 386, MCL 700.1101 to 700.8206.

  • ABI means Anheuser-Busch InBev SA/NV, its domestic and foreign parents, predecessors, divisions, subsidiaries, affiliates, partnerships and joint ventures (excluding Crown, and, prior to the completion of the Transaction, Modelo); and all directors, officers, employees, agents, and representatives of the foregoing. The terms “parent,” “subsidiary,” “affiliate,” and “joint venture” refer to any person in which there is majority (greater than 50 percent) or total ownership or control between the company and any other person.

  • ESMA means the European Securities and Markets Authority.

  • SBS means the New York City Department of Small Business Services.

  • Radiologic technologist, limited means an individual, other than a licensed radiologic technologist,

  • CTI means CTI Logistics Limited (ABN 69 008 778 925) and/or any Affiliate of CTI Logistics Limited as the case may be, which performs all or any of the Services.

  • Catalyst means a substance whose presence enhances the reaction between chemical compounds.

  • Modern biotechnology means the application of:

  • NSC means the National Suppliers Council.

  • IOSCO means the International Organisation of Securities Commissions.

  • SCI has the meaning set forth with respect thereto in the preamble. ---

  • SMP : means Significant Market Power;

  • SPI means the information categories listed at Tex. Bus. & Com. Code § 521.002(a)(2).

  • HKFE means the Hong Kong Futures Exchange Limited.

  • Arena means an enclosed building:

  • SAI means Statement of Additional Information.

  • Merck has the meaning set forth in the preamble.

  • SWDocID [[6180052]]" "" [[6180052]] made on such Increased Amount Date; provided that (i) the conditions set forth in paragraphs of (b) and (c) of Section 4.02 shall be satisfied or waived by the Required Lenders on such Increased Amount Date before or after giving effect to such New Commitments and Loans; (ii) such increase in the Revolving Facility Commitments and/or the Incremental Term Loans shall be evidenced by one or more joinder agreements executed and delivered to Administrative Agent by each New Lender, as applicable, and each shall be recorded in the register, each of which shall be reasonably satisfactory to the Administrative Agent and subject to the requirements set forth in Section 2.17(f); and (iii) the Borrower shall make any payments required pursuant to Section 2.16 in connection with the provisions of the New Commitments; provided that, with respect to any Incremental Term Loans incurred for the primary purpose of financing a Limited Conditionality Acquisition (“Acquisition-Related Incremental Term Loans”), clause (i) of this sentence shall be deemed to have been satisfied so long as (A) as of the date of execution of the related Limited Conditionality Acquisition Agreement by the parties thereto, no Default shall have occurred and be continuing or would result from entry into such Limited Conditionality Acquisition Agreement, (B) as of the date of the borrowing of such Acquisition-Related Incremental Term Loans, no Event of Default under Section 7.01(a), 7.01(b), 7.01(h) or 7.01(i) is in existence immediately before or after giving effect (including on a Pro Forma Basis) to such borrowing and to any concurrent transactions and any substantially concurrent use of proceeds thereof, (C) the representations and warranties of the Loan Parties set forth in this Agreement and the other Loan Documents shall be true and correct in all material respects as of the date of execution of the applicable Limited Conditionality Acquisition Agreement by the parties thereto, except to the extent any such representations or warranties are expressly limited to an earlier date, in which case such representations and warranties shall be true and correct in all material respects as of such specified earlier date (provided that no materiality qualifier set forth in this subclause (C) shall be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof) and (D) as of the date of the borrowing of such Acquisition-Related Incremental Term Loans, customary “Sungard” representations and warranties (with such representations and warranties to be reasonably determined by the Lenders providing such Acquisition-Related Incremental Term Loans) shall be true and correct in all material respects immediately before and after giving effect to the incurrence of such Acquisition-Related Incremental Term Loans, except to the extent any such representations or warranties are expressly limited to an earlier date, in which case such representations and warranties shall be true and correct in all material respects as of such specified earlier date (provided that no materiality qualifier set forth in this subclause (D) shall be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof).